IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 1 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,000 | -45.5% | 52,302 | +14.0% | 0.00% | – |
| Q2 2016 | $11,000 | +10.0% | 45,898 | +28.2% | 0.00% | – |
| Q1 2016 | $10,000 | -47.4% | 35,802 | -33.9% | 0.00% | – |
| Q4 2015 | $19,000 | +35.7% | 54,158 | +57.0% | 0.00% | – |
| Q3 2015 | $14,000 | -51.7% | 34,504 | -42.9% | 0.00% | -100.0% |
| Q2 2015 | $29,000 | -70.7% | 60,438 | -55.4% | 0.00% | -50.0% |
| Q4 2014 | $99,000 | +312.5% | 135,503 | +407.3% | 0.00% | – |
| Q3 2014 | $24,000 | -75.5% | 26,712 | -69.5% | 0.00% | -100.0% |
| Q2 2014 | $98,000 | -17.6% | 87,541 | -10.4% | 0.00% | +100.0% |
| Q1 2014 | $119,000 | -9.2% | 97,689 | -30.9% | 0.00% | 0.0% |
| Q4 2013 | $131,000 | +92.6% | 141,406 | +438.0% | 0.00% | 0.0% |
| Q3 2013 | $68,000 | – | 26,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Callan Capital, LLC | 70,000 | $65,000 | 0.02% |
| Wellington Shields Capital Management, LLC | 51,000 | $47,000 | 0.01% |
| Ifrah Financial Services, Inc. | 18,500 | $17,000 | 0.01% |
| CHELSEA COUNSEL CO | 28,000 | $26,000 | 0.01% |
| DRW Securities, LLC | 120,000 | $111,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 66,303 | $61,000 | 0.00% |
| OPPENHEIMER & CO INC | 107,000 | $99,000 | 0.00% |
| First Allied Advisory Services, Inc. | 45,000 | $42,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $65,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 160,103 | $148,000 | 0.00% |